Two pathogenic mutations in the gene encoding the amyloid precursor protein (APP) are associated with the deposition of amyloid of the P/A4 type [ 11 in the walls of leptomeningeal and cerebrocortical blood vessels. The replacement of glutamate (E) by glutamine (Q) at position 618 of the 695 isoform of APP, which corresponds to residue 22 of P/A4, has been associated with cerebral amyloid angiopathy-Dutch type [2, 3] . This rare autosomal dominant disease results in recurrent cerebral haemorrhage in middle age [4] . A mutation at the adjacent residue 21 of P/A4 (glycine instead of alanine) has been identified in one Dutch family with a history of both pre-senile dementia and cerebrovascular amyloidosis [5] . The pathogenic mechanisms of these mutations are unknown.
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It is well known that synthetic peptides corresponding to full length and fragments of P/A4 aggregate into fibrils with the physical characteristics of amyloid. An increased rate of fibril formation has been observed in fragments containing the Q22 mutation although the rate of aggregation was not measured [6] . We have monitored the aggregation of synthetic peptides corresponding to residues 13-26 of P/A4 to determine if the G21 and 4 2 2 mutations affect the rate of fibril formation of these particular fragments. The peptides studied were Ac-HHQKLVFFAEDVGS-NH, ( Ac-HHQKLVFFAQDV GS-NH, (PII.,,Q22) and Ac-HHQKLVFFGEDVGS-NH, (P13.z6G21).The aggregation of the peptides at several concentrations from 50mM Trid HCI; pH 7.4 at 37 O C was monitored by measuring the amount of peptide remaining in solution at various time points (Fig.1 legend) . Fig.] shows the results at O.Zmg/ml and Img/ml. At Imdml, 60% of PI,.,, and 75% of P,1.26G21 remained in solution after 24 hours, whereas P,,,,Q22 had completely precipitated from solution by this time. Negative stain electron microscopy revealed that the three peptides precipitated as fibrils (diameter 7-15nm) (Fig.2) . When stained with Congo Red, they all exhibited green-red birefringence which is characteristic of amyloid.
These results, together with those obtained at intermediate concentrations (0.5mg/ml and 0.8mglml), demonstrate that the rate of aggregation of &1.26Q22 is dependent on concentration within this range. Results over a similar range reveal that concentration has some influence on the rate of aggregation of However, in the case of P11.26G21r there was no obvious affect of concentration.
Mixtures of PI,.,, with P13.26Q22 or P11.26G21 (0.5rnglml of each in 50 mM Trid HCI; pH 7.4 at 37 "C) were also studied. Our results (not shown) demonstrate that the rate of aggregation of P11.26Q22 is reduced in the presence of PI,.,, (60% remaining after 24 hr) while P11.26G2 1 remains unaffected. PI,.,, aggregated faster in the presence of P13.26Q22 (60% remaining in solution after 24 hr) than in the presence of P11.26G21 (90% remaining in solution).
Our results support the previously reported observation by Wisniewski et al [6] that the 422 mutation increases the propensity of the P/A4 peptide to aggregate into amyloid. The results for P11.26G21, however, suggest that the mechanism of pathogenesis of the G21 mutation is different. The G21 mutation may reduce the cleavage at the a-secretase site [7] resulting in an increased level of processing of APP to P/A4 (possibly at the psecretase site [8] ). Alternatively, it may make P/A4 more resistant to the normal pathways of degradation.
